Digital uroflowmetry for LUTS & BPH

Clinical-grade uroflowmetry.
Just a smartphone.

UroFlo turns the phone patients already own into a validated flow test. It's fast, discreet and secure. Patients test at home and results go straight to their care provider.

Patients studied
180+
NHS boards
3
New hardware
None
UroFlo app showing a uroflow curve with Qmax, voided volume and flow time
Developed and validated withNHS LothianNHS GrampianNHS TaysideHeriot-Watt UniversityChief Scientist Office, Scotland

How it works

Point, void, done. The phone does the measuring.

The UroFlo app uses the phone's camera to track the urine stream in real time and calculate flow rate. It produces the same flow curve and measurements as standard uroflowmetry.

No new hardware

Runs on the patient's own smartphone. No flowmeter, no commode, no kit to ship or recover.

At home, discreetly

Patients void naturally in private, at the times their symptoms actually happen.

No audio or video leaves the device

Flow is computed on the phone. Only the flow data is sent — never images or sound.

Securely shared with care teams

Encrypted results reach the clinician's dashboard straight away, ready for review.

  1. A man in his sixties sitting in an armchair at home, picking up his smartphone to start a UroFlo test

    Step 1 · At home

    Open the app

    The patient opens UroFlo. Nothing to book, collect or return — it runs on the phone they already own.

  2. A closed bathroom door with a small framed picture of a mountain and a potted plant on a shelf beside it

    Step 2 · In private

    Void normally

    They void as usual, holding the phone or resting it on a stand. No special toilet, funnel or commode.

  3. A smartphone propped on a stand in a bathroom showing a uroflowmetry readout — a flow curve with Qmax marked, a volume curve and result figures — facing a toilet in the background

    Step 3 · In real time

    Measured on the phone

    The camera tracks the urine stream and the flow curve is calculated on the phone, second by second.

  4. A smartphone protected by a shield with a check mark, with crossed-out microphone and camera icons nearby

    Step 4 · On device

    Private by design

    Only the flow data is kept. No images, audio or video are ever stored on or sent from the phone.

  5. A doctor at a desk in a clinic reviewing a flow curve report on a secure monitor

    Step 5 · Encrypted

    With the care team

    An encrypted report — the same flow curve and Qmax clinicians already read — lands with the care team for review.

Clinical evidence · NHS Scotland

Results that match standard uroflowmetry

UroFlo has been tested in a series of clinical studies in NHS Scotland, with funding from Scotland's Chief Scientist Office. The results match standard weight-based uroflowmetry for both normal and interrupted flow patterns.

  • 150-patient multi-centre trial

    Run across NHS Lothian and NHS Grampian, it showed UroFlo is as good as the clinical gold standard.

  • 29 of 30 identical diagnoses

    In the first NHS Lothian study, two urologists reviewing results independently reached the same diagnosis.

  • Real-world use in NHS Tayside

    UroFlo is now in use at Ninewells Hospital and a Forfar GP practice.

Flow curve comparison

UroFloGold standard

Continuous Qmax

18.0

vs 19.0 ml/s

Interrupted Qmax

16.5

vs 17.0 ml/s

Handheld vs stand

14.2

vs 14.5 ml/s

Built under an ISO 13485 quality system. Regulatory plans are in place for UKCA, CE and FDA.

Solutions

One platform. Value for everyone in the urology pathway.

Physicians & urology services

Better than in-clinic uroflowmetry

One test in clinic shows one moment. UroFlo shows how the patient really voids, at home, over days or weeks.

  • Multiple at-home voids instead of one anxious test with a full bladder on demand
  • Frees nurse and clinic time — no booking, setup, cleaning or supervision
  • No more cancelled slots, repeat visits or patients who can't void on cue
  • Results in the same flow-curve format clinicians already read (Qmax, volume, flow time, curve shape)
  • Supports virtual triage, so specialist time goes to the patients who need it
US Medicare Advantage providers

Higher quality care, stronger margins under capitation

LUTS/BPH is common in Medicare populations. UroFlo lets risk-bearing providers manage it better at home, at lower cost per member.

  • Catch worsening symptoms early and prevent costly acute events such as urinary retention and ER visits
  • Reduce unneeded specialist referrals and in-person diagnostic visits
  • Track whether treatment is working without bringing members back in
  • Gives better access for rural and mobility-limited members
  • Supports member experience and quality goals that affect Star Ratings
CROs running urology trials

More data points, lower cost per sample

Replace site-visit uroflowmetry with frequent, standardised remote measurements for drug and medical device trials.

  • Many measurements per participant between visits, giving richer data on how the endpoint changes over time
  • The same algorithm on every phone at every site, so results are measured the same way everywhere
  • Pricing per test lowers cost per data point and per site visit
  • Less burden on participants helps recruitment, retention and protocol compliance in decentralised and hybrid trials
  • Results are time-stamped and traceable, and work with the digital trial platforms CROs already use
  • Better data for Qmax and voiding endpoints, with less variation in the results that could hide whether a treatment works
Insurers & payers

Regular flow tracking inside your member portal

Add objective, at-home uroflowmetry to your preventive and chronic care programmes without sending members to a clinic.

  • Fits into the member apps and engagement platforms you already offer
  • Identify population-level risk for urological conditions at scale — reach thousands of members at a fraction of the cost of population screening
  • Regular at-home tests spot men whose symptoms are getting worse earlier
  • Sends members to the right level of care and avoids low-value referrals and tests
  • Objective results to support care management and outcome-based programmes
  • A convenient, private experience that keeps members engaged

Team

Built by engineers and urologists together

YC

Prof. Yuhang Chen

Chief Technology Officer

18 years in biomedical engineering. Led major industry-linked digital measurement programmes, including real-time digital technologies for precision surgery, and the CSO-funded clinical study of digital uroflowmetry in the NHS.

SM

Dr. Scott MacLeod

Technical & Quality Lead

Leads technical development in the UroFlo clinical validation study, with experience delivering industry-focused healthcare technology, including deploying an autonomous care robot.

MT

Mr. Matthew Trail

Chief Clinical Officer

Consultant Urological Surgeon at NHS Lothian leading UroFlo's NHS clinical validation, with expertise in LUTS triage and healthcare technologies.

CO

Mr. Chigozie Onyeze

Clinical Lead, BPH — Tayside

BPH Clinical Lead at Ninewells Hospital, supporting UroFlo's real-world clinical deployment in NHS Tayside.

Bring uroflowmetry home.

Whether you run a urology service, a risk-bearing practice, a clinical trial or a member health programme, let's talk about a pilot.

Request a demo